Toward the development of strategies to prevent ischemic neuronal injury. In vitro studies

Annals of the New York Academy of Sciences

Volumn 825, Issue , 1997, Pages 209-219

  Marini, Ann M ^a,b   Spiga, Giulio ^c,d   Mocchetti, Italo ^c,d  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EXCITOTOXIN; GLUTAMIC ACID; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTROPHIC FACTOR; PROTEIN;

ANIMAL CELL; APOPTOSIS; CEREBELLUM; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; GRANULE CELL; ISCHEMIA; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN SYNTHESIS; RAT;

ANIMALIA;

EID: 0030733208     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48431.x     Document Type: Conference Paper

References (46)

1. OLNEY, J. W., O. L. HO & V. RHEE. 1971. Cytotoxic effects of acidic and sulphur-containing amino acids on the infant mouse central nervous system. Exp. Brain Res. 14: 61-76.
2. ROTHMAN, S. M. & J. W. OLNEY. 1986. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19: 105-111.
3. CHOI, D. W. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634.
4. WIELOCK, T., B. ENGELSEN, E. WESTERBERG & R. AUER. 1985. Lesions of the glutamatergic corticostriatal projections in the rat ameliorate hypoglycemic brain damage in the striatum. Neurosci. Lett. 58: 25-30.
5. WIELOCK, T. 1985. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230: 681-683.
6. OLNEY, J. W. 1989. Excitatory amino acids and neuropsychiatric disorders. Biol. Psychiatry 26: 505-525.
7. MACDERMOTT, A. B., M. L. MAYER, G. L. WESTBROOK, S. J. SMITH & J. L. BARKER. 1986. NMDA-receptor activation increases cytoplasmic calcium concentrations in cultured spinal cord neurones. Nature 321: 519-522.
8. CHOI, D. W. 1988. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11: 465-469.
9. LEVI, G. F., M. T. ALOISI, M. CIOTTI & V. GALLO. 1984. Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures. Brain Res. 290: 77-86.
10. GALLO, V., R. SUIERGIU, C. GIOVANNINI & G. LEVI. 1987. Glutamate receptor subtypes in cultured cerebellar neurons: modulation of glutamate and gamma-aminobutyric acid release. J. Neurochem. 49: 1801-1809.
11. NOVELLI, A., J. A. REILLY, P. G. LYSKO & R. C. HENNEBERRY. 1988. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451: 205-212.
12. MARINI, A. M. & S. M. PAUL. 1992. N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc. Natl. Acad. Sci. USA 89: 6555-6559.
13. SCHRAMM, M., S. EIMERL & E. COSTA. 1990. Serum and depolarizing agents cause neurotoxicity in cultured cerebellar granule cells: role of the glutamate receptor responsive to N-methyl-D-aspartate. Proc. Natl. Acad. Sci. USA 87: 1193-1197.
14. MANEV, H., E. COSTA, J. T. WROBLEWSKI & A. GUIDOTTI. 1990. Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity. FASEB J. 4:1990-1906.
15. MARINI, A. M., J. P. SCHWARTZ & I. J. KOPIN. 1989. The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells. J. Neurosci. 9: 3665-3672.
16. DUNCAN, M. W., A. M. MARINI, R. WATTERS, I. J. KOPIN & S. P. MARKEY. 1992. Zinc, a neurotoxin to cultured neurons, contaminates cycad flour prepared by traditional guamanian methods. J. Neurosci. 12: 1523-1537.
17. WYLLIE, A. H., J. F. R. KERR & A. R. CURRIE. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-307.
18. MARINI, A. M., F. FINIELS-MARLIER, B. DIPASQUALE, S. PAUL & R. YOULE. 1993. Glutamate induces apoptotic cell death in primary cultures of the nervous system. Soc. Neurosci. Abst. 553.19: 1344.
19. DIPASQUALE, B., A. M. MARINI & R. J. YOULE. 1991. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem. Biophys. Res. Commun. 181: 1442-1448.
20. MARTIN, D. P., R. E. SCHMIDT, P. S. DISTEPHANO, O. H. LOWRY, J. G. CARTER & E. M. JOHNSON. 1988. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106: 829-844.
21. MOCCHETTI, I. & J. R. WRATHALL. 1995. Neurotrophic factors in central nervous system trauma. J. Neurotrauma 12: 853-870.
22. BURGESS, W. & T. MACIAG. 1989. The heparin-binding growth factor family of proteins. Annu. Rev. Biochem. 58: 575-590.
23. RIVA, M. & I. MOCCHETTI. 1991. Developmental expression of the basic fibroblast growth factor gene in rat brain. Dev. Brain Res. 62: 45-50.
24. EMOTO, N., A.-M. GONZALES, P. A. WALICKE, E. WADA, D. M. SIMMONS, S. SHIMASAKI & A. BAIRD. 1989. Basic fibroblastic growth factor in the central nervous system: identification of specific loci of basic FGF expression in the rat brain. Growth Factors 2:21-29.
25. FERRARI, G., M. C. MINOZZI, G. TOFFANO, A. LEON & S. D. SKAPER. 1989. Basic fibroblastic growth factor promotes the survival and development of mesencephalic neurons in culture. Dev. Biol. 133: 140-147.
26. MORRISON, R. S., A. SHARMA, J. DEVELLIS & R. A. BRADSHAW. 1986. Basic fibroblastic growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl. Acad. Sci. USA 83: 7537-7541.
27. WALICKE, P. A. 1988. Basic and acidic fibroblastic growth factor have trophic effect on neurons from multiple CNS regions. J. Neurosci. 8: 2618-2627.
28. ANDERSON, K. J., D. DAM, S. LEE & C. W. COTMAN. 1988. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. 332: 360-361.
29. OTTO, D., K. UNSICKER & C. GROTHE. 1988. Basic fibroblast growth factor and nerve growth factor administered in gel foam rescues medial septal neurons after fibria fornix transection. J. Neurosci. Res. 22: 83-91.
30. CHENG, B. & M. P. MATTSON. 1991. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7: 1031-1041.
31. OTTO, D. & K. UNSICKER. 1990. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10: 1912-1921.
32. FREESE, A., S. P. FINKLESTEIN & M. DIFIGLIA. 1992. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA receptor-mediated excitotoxicity. Brain Res. 575: 351-355.
33. FRIM, D. M., T. A. UHLER, P. M. SHORT, D. Z. EZZEDINE, M. KLAGSBRUN, X. O. BREAKEFIELD & O. ISACSON. 1993. Effects of biologically delivered, NGF, BDNF, and bFGF on striatal excitotoxic lesions. NeuroReport 4: 367-370.
34. FERNANDEZ-SANCHEZ, M. T. & A. NOVELLI. 1993. Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor-mediated neurotoxicity. FEBS Lett. 29: 124-131.
35. FINKLESTEIN, P., P. J. APOSTOLIDES, C. G. CADAY, J. PROSSER, M. F. PHILIPS & M. KLAGSBRUN. 1988. Increased basic fibroblast growth factor immunoreactivity at the site of focal brain wound. Brain Res. 360: 253-259.
36. MOCCHETTI, I., S. J. RABIN, A. M. COLANGELO, S. R. WHITTEMORE & J. R. WRATHALL. 1996. Increased basic fibroblast growth factor expression following contusive spinal cord injury. Exp. Neurol. 141: 154-164.
37. RIVA, M., K. GALE & I. MOCCHETTI. 1992. Basic fibroblast growth factor mRNA increases in specific brain regions following convulsive seizures. Mol. Brain Res. 15: 311-318.
38. FOLLESA, P., K. GALE & I. MOCCHETTI. 1994. Regional and temporal pattern of expression of nerve growth factor and basic fibroblast growth factor mRNA in rat brain following electroconvulsive shock. Exp. Neurol. 127: 37-44.
39. CHOI, D. W. 1992. Excitotoxic cell death. J. Neurobiol. 23: 126-176.
40. ALBERS, G. W., M. P. GOLDBERG & D. W. CHOI. 1989. N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Ann. Neurol. 25: 398-403.
41. FRIDEN, P. M., L. R. WALUS, P. WATSON, S. R. DOCTROW, J. W. KOZARICH, C. BACKMAN, H. BERGAM, B. HOFFER, F. BLOOM & A. C. GRANHOLM. 1993. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259: 373-377.
42. 1 ganglioside activates the high-affinity nerve growth factor receptor trkA. J. Neurochem. 65: 347-354.
43. YUREK, D. M. & J. R. SLADEK, JR. 1990. Dopamine cell replacement: Parkinson's disease. Annu. Rev. Neurosci. 13: 415-440.
44. MOCCHETTI, I. 1991. Theoretical basis for a pharmacology of nerve growth factor biosynthesis. Ann. Rev. Pharmacol. Toxicol. 32: 303-328.
45. FOLLESA, P. & I. MOCCHETTI. 1993. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by β-adrenergic receptor activation and adrenal steroids in rat CNS. Mol. Pharmacol. 43: 132-138.
46. MOCCHETTI, I., G. SPIGA, V. Y. HAYES, P. J. ISACKSON & A. M. COLANGELO. 1996. Glucocorticoids differentially increase nerve growth factor and basic fibroblast growth factor expression in the rat brain. J. Neurosci. 16: 2141-2148.